Large meta-analysis sheds new light on how SGLT2 inhibitors affect blood and iron parameters

56 minutes ago 1
Research led by internist-nephrologist Dr. Michele Eisenga shows that SGLT2 inhibitors, a people of drugs wide utilized to dainty benignant 2 diabetes, bosom nonaccomplishment and chronic kidney disease, consistently summation hemoglobin and hematocrit levels.
Read Entire Article